The plaintiffs bar has argued that courts can only preempt prescription pharmaceutical state law failure-to-warn claims when ...

At a Case Management Conference in the Multi District Litigation against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first Trial, which will take place in December 2026, ...

Depo-Provera is an injectable form of birth control manufactured by Pfizer that contains a synthetic hormone, medroxyprogesterone acetate, which prevents pregnancy by stopping ovulation, thickening ...

The FDA approved a new safety warning for Depo-Provera alerting patients to a possible risk for a type of brain tumor called ...

If you’ve experienced serious side effects after using Depo-Provera, you are not alone. The birth control injection has been linked to a range of adverse health effects, including bone density loss, ...

Christy Bieber has a JD from UCLA School of Law and began her career as a college instructor and textbook author. She has been writing full time for over a decade with a focus on making financial and ...

Since the beginning of the year, there has been a rise in the number of lawsuits against pharma giant Pfizer over its injectable contraception, Depo-Provera. Consumers have increasingly joined ...

According to the Centers for Disease Control and Prevention (CDC), as of 2017, 65.3% of women between the ages of 15 and 49 in the United States use a form of birth control. Of this population, 10.4% ...

WESTWEGO, La. — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. For years, ...

Depo Provera Brain Tumor: Medroxyprogesterone acetate, a contraceptive injection containing the hormone progestin, is widely known by its brand name, Depo-Provera. Administered every three months, it ...

Decades after receiving regular injections of the hormonal contraceptive Depo-Provera, an estimated 1,300 women are now suing manufacturer Pfizer, alleging the company failed to adequately warn users ...